INTRODUCTION
Chronic renal disease (CRD) is a common health problem resulting from loss of kidney function. Diabetes and high blood pressure are the most common causes for its occurence 1, 2 .
The number of patients with CRD in China is estimated to be approximately 119.5 million. A cross sectional survey of a nationally representative sample of Chinese adults demonstrated that the prevalence of CRD varied widely among geographic regions, with an overall prevalence of 10.8% 2 . The prevalence in China is slightly higher compared to developed nations such as the United States (9.4% for [2005] [2006] [2007] [2008] [2009] [2010] 3 and the United Kingdom (8.5%) 4 .
The burden of CRD is not restricted to its effect on demands for renal replacement therapy; the disease has other major effects on the overall population. Both, in the general population, and in high-risk diabetics, kidney involvement affects mortality and cardiovascular events 5 .
Rapid increase in the prevalence of risk factors such as diabetes, hypertension, and obesity could result in an even greater burden of chronic kidney disease in the future, and is likely to have substantial socioeconomic and public health consequences in resource-poor countries 5 .
The present comprehensive literature review was conducted to collate the published evidence evaluating economic implications of CRD with and without co-morbid diabetes mellitus in China (post-2005 All abstracts retrieved by the searches were reviewed against the pre-defined inclusion criteria (Figure 1) , and data extractions of relevant studies were performed by two independent reviewers with any discrepancy resolved by a third independent reviewer.
Costs including direct and indirect costs associated with CRD and its complications were extracted along with cost years and study perspectives. Cost data were extracted either as reported in the studies or were converted from USD to Chinese Yuan based on the conversion factor reported in such studies 7, 8 .
CONCLUSIONS
Progression of chronic renal disease with or without co-morbid diabetes drives substantial medical care costs in China. Total medical expenditures for treating CRD were considerably greater for patients with associated diabetic complication compared to those without such complications. Reviewing the studies on economic aspects presented higher costs for hemodialysis compared to peritoneal dialysis in China. However, this literature review has certain limitations in terms of a small number of English language studies retrieved from the searches. As CRD prevalence continues to grow in Chinese society in the coming years, future research in CRD should be usefully directed towards analyzing the economic consequences for better management of the increase in societal and direct medical costs. Economic burden of hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) in patients with end-stage renal disease was assessed by Zhang and colleagues 10 to establish cost-effective treatment modalities from Chinese societal perspective. It was observed that patients undergoing HD incurred higher costs relative to those undergoing CAPD (Table 1) Citations meeting first screening criteria: 28
Citations meeting second screening criteria and ready for data extraction: 5
